alanine has been researched along with alafosfalin in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (77.78) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (7.41) | 29.6817 |
2010's | 3 (11.11) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Allen, JG; Atherton, FR; Hall, MJ; Hassall, CH; Holmes, SW; Lambert, RW; Nisbet, LJ; Ringrose, PS | 1 |
Allen, JG; Havas, L; Leicht, E; Lenox-Smith, I; Nisbet, LJ | 1 |
Arisawa, M; Maruyama, HB; Sawada, T | 1 |
Atherton, FR; Hall, MJ; Hassall, CH; Lambert, RW; Lloyd, WJ; Ringrose, PS | 1 |
Atherton, FR; Hassall, CH; Lambert, RW | 1 |
Poliak, MS | 1 |
Kafarski, P; Lejczak, B; Mastalerz, P; Sztajer, H | 1 |
Giovenella, AJ; Grappel, SF; Nisbet, LJ | 1 |
Gibson, MM; Higgins, CF; Price, M | 1 |
Angehrn, P; Hall, MJ; Lloyd, WJ; Westmacott, D | 1 |
Neuman, M | 1 |
Hall, MJ; Middleton, RF; Westmacott, D | 1 |
Andrews, JM; Dean, S; Kendall, MJ; Welling, PG; Wise, R | 1 |
Mhalu, FS; O'Grady, F; Pearson, NJ; Towner, KJ | 1 |
Traub, WH | 1 |
Atherton, FR; Hall, MJ; Hassall, CH; Holmes, SW; Lambert, RW; Lloyd, WJ; Ringrose, PS | 1 |
Atherton, FR; Hall, MJ; Hassall, CH; Holmes, SW; Lambert, RW; Lloyd, WJ; Nisbet, LJ; Ringrose, PS; Westmacott, D | 1 |
Cars, O; Henning, C | 1 |
Arisawa, M; Maruyama, HB; Ohsawa, E; Ohshima, J | 1 |
Hahn, FE | 1 |
Allen, JG; Lees, LJ | 1 |
Boissier, E; Freydière, AM; Gould, FK; Ouedraogo, RT; Perez, JM; Perry, JD; Riley, G | 1 |
Brandsch, M; Bruch, M; Gebauer, S; Neumann, J | 1 |
Doki, S; Hattori, M; Ishitani, R; Iwaki, M; Iwase, N; Kandori, H; Kato, HE; Koyama, M; Newstead, S; Nureki, O; Solcan, N; Sugita, Y; Tsukazaki, T | 1 |
Guettou, F; Jegerschöld, C; Jong, AJ; Löw, C; Moberg, P; Nordlund, P; Quistgaard, EM; Trésaugues, L; Zhu, L | 1 |
Bougioukou, DJ; Mukherjee, S; Peck, SC; Ting, CP; van der Donk, WA | 1 |
Howe, Z; Huesgen, E; Moore, SE | 1 |
1 review(s) available for alanine and alafosfalin
Article | Year |
---|---|
[Antibiotics of the phosphonic acid group].
Topics: Alanine; Animals; Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
1 trial(s) available for alanine and alafosfalin
Article | Year |
---|---|
Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.
Topics: Alanine; Cell Wall; Cephalexin; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Female; Food; Humans; Hydrolysis; Kinetics; Male; Peptides; Phosphopeptides; Time Factors; Urinary Tract Infections | 1980 |
25 other study(ies) available for alanine and alafosfalin
Article | Year |
---|---|
Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides.
Topics: Alanine; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Culture Media; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Kinetics; Male; Mice; Microbial Sensitivity Tests; Organophosphorus Compounds; Peptide Hydrolases; Phosphopeptides; Rats; Sepsis | 1979 |
Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans.
Topics: Alanine; Animals; Anti-Infective Agents; Biotransformation; Female; Haplorhini; Humans; Kinetics; Male; Papio; Phosphopeptides; Protein Binding; Rats; Time Factors; Tissue Distribution | 1979 |
Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.
Topics: Alanine; Anti-Bacterial Agents; Bacteria; Bacteriuria; beta-Lactams; Cell Wall; Drug Resistance, Microbial; Drug Synergism; Humans; Japan; Microbial Sensitivity Tests; Phosphopeptides | 1979 |
Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin.
Topics: Alanine; Alanine Racemase; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Cell Wall; DNA, Bacterial; Organophosphorus Compounds; Phosphopeptides; RNA, Bacterial; Uridine Diphosphate | 1979 |
Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid.
Topics: Alanine; Aminoethylphosphonic Acid; Animals; Anti-Bacterial Agents; Bacteria; Biological Transport, Active; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Haemophilus influenzae; Mice; Organophosphonates; Organophosphorus Compounds; Peptides; Streptococcus; Structure-Activity Relationship | 1986 |
Antibacterial activity of phosphono dipeptides related to alafosfalin.
Topics: Alanine; Anti-Bacterial Agents; Bacteria; Dipeptides; Structure-Activity Relationship | 1986 |
Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria.
Topics: Alanine; Anti-Bacterial Agents; Bacteria, Anaerobic; Culture Media; Cycloserine; Microbial Sensitivity Tests; Penicillin G | 1985 |
Genetic characterization and molecular cloning of the tripeptide permease (tpp) genes of Salmonella typhimurium.
Topics: Alanine; Anti-Bacterial Agents; Bacterial Proteins; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; DNA Restriction Enzymes; DNA Transposable Elements; Drug Resistance, Microbial; Genes; Genes, Bacterial; Genotype; Membrane Transport Proteins; Mutation; Phenotype; Salmonella typhimurium | 1984 |
Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.
Topics: Alanine; Animals; Anti-Bacterial Agents; Bacteriolysis; Drug Synergism; Gram-Negative Bacteria; Lactams; Mice; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Sepsis | 1984 |
Recent developments in the field of phosphonic acid antibiotics.
Topics: Alanine; Animals; Anti-Bacterial Agents; Fosfomycin; Humans | 1984 |
The fractional inhibitory concentration (FIC) index as a measure of synergy.
Topics: Alanine; Anti-Bacterial Agents; Bacteria; Cephalexin; Drug Synergism; Microbial Sensitivity Tests | 1983 |
Effect of food on the bioavailability of alafosfalin, a new antibacterial agent.
Topics: Administration, Oral; Adult; Alanine; Animals; Anti-Infective Agents; Biological Availability; Dietary Proteins; Female; Food; Humans; Intestinal Absorption; Kinetics; Male; Milk; Models, Biological; Phosphopeptides; Water | 1980 |
Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania.
Topics: Alanine; Anti-Bacterial Agents; Cholera; Drug Resistance, Microbial; Extrachromosomal Inheritance; Humans; Tanzania; Vibrio cholerae | 1980 |
In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.
Topics: Alanine; Anti-Bacterial Agents; Carbenicillin; Cefamandole; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Penicillin Resistance; Phosphopeptides; Serratia marcescens | 1980 |
Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.
Topics: Alanine; Animals; Anti-Bacterial Agents; Bacteria; Dipeptides; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Phosphopeptides; Structure-Activity Relationship | 1980 |
Antibacterial properties of alafosfalin combined with cephalexin.
Topics: Alanine; Amdinocillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteriolysis; Cephalexin; Drug Synergism; Escherichia coli; Salmonella typhimurium; Staphylococcus; Streptococcus | 1981 |
Penetration of alafosfalin and ampicillin into tissue cage fluid in rabbits.
Topics: Alanine; Ampicillin; Animals; Anti-Infective Agents; Body Fluids; Kinetics; Models, Biological; Rabbits; Time Factors | 1982 |
In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.
Topics: Alanine; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillin G; Species Specificity; Urinary Tract Infections | 1982 |
Alafosfalin, a new synthetic antibacterial compound.
Topics: Alanine; Anti-Bacterial Agents; Bacteria; Drug Evaluation, Preclinical; Phosphopeptides; Species Specificity | 1981 |
Alafosfalin as a selective agent for isolation of salmonella from clinical samples.
Topics: Alanine; Bacteriological Techniques; Chromogenic Compounds; Culture Media; Drug Resistance, Bacterial; Feces; Gram-Negative Bacteria; Humans; Salmonella; Sensitivity and Specificity | 2002 |
Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Topics: Alanine; Animals; Biological Transport; Caco-2 Cells; Carbon Radioisotopes; Carrier Proteins; Cell Line; Dipeptides; Electrophysiology; Epithelial Cells; Humans; Intestinal Mucosa; Intestines; Intracellular Space; Kidney; Peptide Transporter 1; Rats; Symporters | 2004 |
Structural basis for dynamic mechanism of proton-coupled symport by the peptide transporter POT.
Topics: Alanine; Carrier Proteins; Ion Transport; Models, Molecular; Molecular Dynamics Simulation; Peptides; Protein Conformation; Protons | 2013 |
Structural insights into substrate recognition in proton-dependent oligopeptide transporters.
Topics: Alanine; Amino Acid Sequence; Bacterial Proteins; Molecular Docking Simulation; Molecular Sequence Data; Protein Binding; Shewanella; Symporters | 2013 |
Use of the dehydrophos biosynthetic enzymes to prepare antimicrobial analogs of alaphosphin.
Topics: Alanine; Anti-Bacterial Agents; Biocatalysis; Leucine-tRNA Ligase; Molecular Conformation; Streptomyces | 2019 |
Sustained virologic suppression with abacavir, emtricitabine, and crushed dolutegravir and tenofovir alafenamide in a patient with HIV and eosinophilic esophagitis.
Topics: Adult; Alanine; Anti-HIV Agents; Deglutition Disorders; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Eosinophilic Esophagitis; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Oxazines; Piperazines; Pyridones; Tenofovir; Treatment Outcome; Viral Load | 2020 |